Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dual-heart disease animal model construction method based on syndrome of intermingled phlegm and blood stasis and feed composition

A technology of phlegm and blood stasis and animal model, which is applied in the medical field, can solve the problems of high rat mortality, lack of exercise, no reported composite animal model of coronary heart disease combined with depression, etc., and achieve low mortality and rat mortality high effect

Pending Publication Date: 2021-10-26
GUANGXI UNIV OF CHINESE MEDICINE
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] (2) If myocardial ischemia is caused by ligation of the left anterior descending coronary artery in rats, the mortality rate of rats is also very high;
[0007] (3) Due to the widespread existence of people overeating fat, sweet and delicious food, lack of exercise, and many patients with coronary heart disease also have hyperlipidemia, there is currently no literature report on a rat model of myocardial ischemia in a state of hyperlipidemia
[0008] (4) There is currently no report of a composite animal model of coronary heart disease combined with depression

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dual-heart disease animal model construction method based on syndrome of intermingled phlegm and blood stasis and feed composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] In order to make the object, technical solution and advantages of the present invention more clear, the present invention will be further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.

[0023] In view of the problems existing in the prior art, the present invention provides a method for constructing an animal model of double-heart disease based on the syndrome of phlegm and blood stasis in a high-fat state. The present invention will be described in detail below with reference to the accompanying drawings.

[0024] The invention provides a high-fat feed formula in the construction of an animal model of double-heart disease based on the syndrome of intertwined phlegm and blood stasis in a high-fat state. The feed formula consists of 2% cholesterol, 5% lard, 0.2% sodium cholate, 20% sucrose and 72.8% basic f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and discloses a dual-heart disease animal model construction method, time and feed formula based on the syndrome of intermingled phlegm and blood stasis. A rat high-fat feed formula comprises 2% of cholesterol, 5% of lard, 0.2% of sodium cholate, 20% of cane sugar and 72.8% of basal feed. The method comprises the following steps that: feeding with the rat high-fat feed for 8 weeks is performed; on the first day of modelling, rats receive various unpredictable stresses every day, including nine kinds of stimuli such as fasting for 24 hours, depriving for 24 hours, swimming in ice water, binding for 3 hours, shaking mouse cages, reversing day and night, heating, overnight wet padding and overnight inclination of mouse cages at the temperature of 45 DEG C; the same kind of stimuli discontinuously appear, so that the animals cannot be subjected to unpredictable stimuli; 3 mg / kg of Isoprotenol hydrochloride is subcutaneously injected to the abdomen every day from the sixth week of moulding; and the injection is continued for 3 weeks. The method disclosed by the invention is high in operability, low in animal death rate, easy to evaluate, and low in cost, and is a dual-heart disease animal model with combined diseases and syndromes and intermingled phlegm and blood stasis syndromes.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a method for constructing an animal model of double-heart disease based on the syndrome of mutual accumulation of phlegm and blood stasis, and a feed composition. Background technique [0002] Coronary atherosclerotic heart disease (CHD) is referred to as coronary heart disease. Coronary heart disease is one of the diseases with the highest fatality rate in the world, and it is currently the first cause of death recognized by the World Health Organization (WHO) [1] . Depression is a mental and emotional disorder with persistent low mood as the main symptom, characterized by high prevalence, high relapse rate, and high suicide rate [2] . According to the WHO report, there are currently 322 million patients with depression worldwide, and the number of patients has increased by 18.4% from 2005 to 2015. [3] , by 2020, depression will be the second leading disease in ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23K20/158A23K20/163A23K20/168A23K20/105A23K50/50A01K67/02
CPCA23K20/158A23K20/163A23K20/168A23K20/105A23K50/50A01K67/02A01K2207/25A01K2227/105A01K2267/0375
Inventor 杨力强李晓红孔鹏云肖华业龙春莉高琳
Owner GUANGXI UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products